Trial Profile
A phase III study of OC-459 (Timapiprant) for the treatment of atopic eosinophilic asthma in adults
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Timapiprant (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Therapeutic Use
- 08 Oct 2016 New trial record